Lemaire V, Kuntz D, Ryckewaert A
Rev Rhum Mal Osteoartic. 1975 Feb;42(2):93-6.
The authors treated 17 patients with hypercalcaemia (which in 16 cases resulted from a malignant disease) by means of 1 to 3 daily perfusions of 25 g of mithramycin per kg body weight. In all patients the treatment resulted in reduction in the level of calcaemia. In 12 patients the level of calcaemia was reduced to less than 105 mg/litre; in 16 patients to less than 110 mg/litre. In no patient was the calcaemia reduced to less than 70 mg/litre. The only notable inconvenience of the treatment was vomiting during the perfusion. Mithramycin seems to be the treatment of choice for hypercalcaemia of cancerous origin.
作者采用每日每千克体重1至3次灌注25克光辉霉素的方法治疗了17例高钙血症患者(其中16例由恶性疾病引起)。所有患者经治疗后血钙水平均有所降低。12例患者的血钙水平降至105毫克/升以下;16例患者降至110毫克/升以下。没有患者的血钙水平降至70毫克/升以下。治疗唯一明显的不便之处是灌注过程中出现呕吐。光辉霉素似乎是癌源性高钙血症的首选治疗药物。